Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19
NCT04659304
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Allocetra-OTS
Sponsor
Enlivex Therapeutics Ltd.